These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25461907)

  • 21. Modulated hemodynamic response to clonidine in bile duct-ligated rats: the role of nitric oxide.
    Tavakoli S; Hajrasouliha AR; Jabehdar-Maralani P; Ebrahimi F; Sadeghipour H; Dehghani M; Shafaroodi H; Dehpour AR
    Eur J Pharmacol; 2006 Aug; 542(1-3):148-53. PubMed ID: 16824510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids.
    Borhani AA; Houshmand G; Samini M; Namiranian K; Hajrasouliha AR; Tavakoli S; Ebrahimi F; Dehpour AR
    Eur J Pharmacol; 2005 May; 514(2-3):183-9. PubMed ID: 15910805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats.
    Wang G; Shen H; Rajaraman G; Roberts MS; Gong Y; Jiang P; Burczynski F
    Eur J Pharmacol; 2007 Mar; 560(1):61-8. PubMed ID: 17292345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-dependent reduction of acetylcholine-induced relaxation in aortic rings of cholestatic rats.
    Rastegar H; Jorjani M; Roushanzamir F; Ahmadiani A; Namiranian K; Dehpour AR
    Pharmacol Res; 2001 Dec; 44(6):519-25. PubMed ID: 11735360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.
    El-Mir MY; Monte MJ; Morales AI; Arevalo M; Serrano MA; Marin JJ
    Hepatology; 1997 Sep; 26(3):527-36. PubMed ID: 9303479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
    Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
    J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-dependent reduction of acetylcholine-induced relaxation in corpus cavernosum of cholestatic rats: role of nitric oxide and cyclooxygenase pathway.
    Dehghani M; Sadeghipour H; Shafaroodi H; Honar H; Riazi K; Ebrahimkhani MR; Hajrasouliha AR; Tavakoli S; Dehpour AR
    Eur J Pharmacol; 2004 Aug; 496(1-3):181-7. PubMed ID: 15288589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
    Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
    Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
    Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
    Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
    Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
    Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sodium tauroursodeoxycholate (UR-906) on liver dysfunction in bile duct-ligated rats.
    Ishizaki K; Kinbara S; Miyazawa N; Takeuchi Y; Hirabayashi N; Kasai H; Araki T
    Eur J Pharmacol; 1997 Aug; 333(2-3):207-13. PubMed ID: 9314037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of glutathione depletion and hydrophilic bile acids on hepatic acute phase reaction in rats with extrahepatic cholestasis.
    Roeb E; Purucker E; Gartung C; Geier A; Jansen B; Winograd R; Matern S
    Scand J Gastroenterol; 2003 Aug; 38(8):878-85. PubMed ID: 12940443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
    Luketic VA; Sanyal AJ
    Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cholestasis: drug therapy].
    Leuschner U
    Praxis (Bern 1994); 1998 Nov; 87(46):1532-6. PubMed ID: 9857764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway.
    Serrano MA; Macias RI; Vallejo M; Briz O; Bravo A; Pascual MJ; St-Pierre MV; Stieger B; Meier PJ; Marin JJ
    J Pharmacol Exp Ther; 2003 May; 305(2):515-24. PubMed ID: 12606635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis.
    Di Guida F; Pirozzi C; Magliocca S; Santoro A; Lama A; Russo R; Nieddu M; Burrai L; Boatto G; Mollica MP; Sodano F; Lazzarato L; Chegaev K; Meli R; Raso GM; Rimoli MG
    Mol Pharm; 2018 Jan; 15(1):21-30. PubMed ID: 29140706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats.
    Aksu B; Umit H; Kanter M; Guzel A; Aktas C; Civelek S; Uzun H
    Acta Histochem; 2010 May; 112(3):259-69. PubMed ID: 19217652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acids content in brain of common duct ligated rats.
    Tripodi V; Contin M; Fernández MA; Lemberg A
    Ann Hepatol; 2012; 11(6):930-4. PubMed ID: 23111582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicity studies of WY-14,643 (CAS No. 50892-23-4) administered in feed to male Sprague-Dawley rats, B6C3F1 mice, and Syrian hamsters.
    Cunningham ML
    Toxic Rep Ser; 2007 Oct; (62):1-136. PubMed ID: 24743700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic therapy with ursodeoxycholic acid in a child with Alagille syndrome].
    Clerici C; Gentili G; Dozzini G; Distrutti E; Solinas A; Vedovelli A; Pelli MA; Bragetti P; Setchell K; Morelli A
    Pediatr Med Chir; 1993; 15(5):521-3. PubMed ID: 8159589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.